Clinical Trials on Risk Assessment of Chronic Atrophic Gastritis Malignant Transformation in Brazil
Total 0 results
Nothing found
Sponsors and Collaborators
- Gulsah Ilhan
- Ana Paula Costella
- Walgreens Co.
- Korrus Inc.
- Laboratorios Viñas, S.A.
- Fundación Pública Andaluza Progreso y Salud
- Prof. Abdel-Megeeed I. Abdel- Megeeed
- IRCCS Don Gnocchi, Milano, Italy
- Pharmaspecific
- Michael J. Wesley, PhD
- Edanz Group Japan Ltd
- Army Hospital, Percy
- Affiliated Hospital of Yunnan University of Traditional Chinese Medicine
- Manmohan Cardiothoracic Vascular and Transplant Center
- Frankel, Amylynne, M.D.
- HeartPoint Global
- Center for Rare Neurological Diseases, Norcross, GA
- Centre of Malariology Parasitology and Entomology, Department of Communicable Diseases Control, Ministry of Health, Lao PDR
- Ruba Musharbash Nutrition Consultancy Center
- King Baudouin Foundation
- View Full List
Medical Conditions
- Cardiovascular Outcomes
- Menopause
- Impairment, Coordination
- Developmental Language Disorder and Language Impairment
- Cognitive Function, Social 1
- Severe Atopic Dermatitis
- Gastroenteritis Rotavirus
- Localized Unresectable Adult Primary Liver Cancer
- Coagulation Disorder Neonatal
- Uncontrolled Type 2 Diabetes Mellitus
- Paralysis of Vocal Cords or Larynx
- Patients Undergoing Coronary Artery Bypass Graft (CABG) Surgery Requiring Extracorporeal Circulation
- Facial Involvement
- Lung Neuroendocrine Tumor
- Kidney Damage
- Malignant Intracranial Germ Cell Tumor
- Pelvis Tumors
- Ankylosed Teeth
- Brain Arteriovenous Malformation
- Ann Arbor Stage IVB Hodgkin Lymphoma
- View Full List
Drug Interventions
- 5-Fluorouracil
- Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
- Thiotepa
- Methotrexate
- Dexmedetomidine
- Ozanimod
- Insulin
- Transdermal estradiol
- Exendin 9-39
- Interferon beta-1b (Betaferon, BAY86-5046)
- Interleukin-2
- Apremilast
- FHND5071
- Rituximab plus CHOP
- CD25 treatment
- Miglustat
- LDEPA
- Extended release guanfacine
- Camrelizumab for injection (200 mg, iv), D1, Q2W, 14-day cycle
- Lidocaine/ ketamine
- View Full List
CROs by country
- Contract Research Organizations in Bahrain
- Contract Research Organizations in Chile
- Contract Research Organizations in Costa Rica
- Contract Research Organizations in Czech Republic
- Contract Research Organizations in Liberia
- Contract Research Organizations in Lithuania
- Contract Research Organizations in Macedonia
- Contract Research Organizations in Malaysia
- Contract Research Organizations in Mali
- Contract Research Organizations in Montenegro
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Senegal
- Contract Research Organizations in South Korea
- CRO list by country